Updated: February 20, 2026
How to Help Your Patients Find Evekeo in Stock: A Provider's Guide
Author
Peter Daggett

Summarize with AI
A practical guide for providers on helping patients find Evekeo during the shortage. Includes 5 actionable steps, alternative options, and workflow tips.
Helping Your Patients Find Evekeo in Stock
As a prescriber, you already know the stimulant shortage is impacting your patients. But for those on Evekeo (amphetamine sulfate), the challenge is even greater. Evekeo's niche 1:1 racemic amphetamine formulation, limited manufacturer base, and small market share make it one of the hardest stimulants to source in 2026.
Your patients are frustrated, and many are spending hours calling pharmacies only to hear "we don't have it" over and over. This guide gives you practical steps to help — from verifying stock before prescribing to developing contingency plans.
Current Availability Landscape
As of early 2026, Evekeo availability remains inconsistent across the country. Key factors driving the shortage include:
- Single primary manufacturer: Azurity Pharmaceuticals is the main source of both Evekeo tablets and Evekeo ODT
- DEA quota constraints: Schedule II manufacturing quotas limit how much amphetamine sulfate can be produced annually
- Low pharmacy stocking rates: Many chain pharmacies don't carry Evekeo as a standard inventory item due to low prescription volume
- Wholesaler allocation: During shortage periods, wholesalers may allocate limited supply based on a pharmacy's historical ordering patterns
The result: even when Evekeo is technically in production, getting it to the right pharmacy at the right time remains a challenge.
Why Patients Can't Find Evekeo
Understanding the patient experience helps frame your approach:
- Chain pharmacies say "not in stock": Most large chains don't regularly carry Evekeo and can't easily order it during shortages
- Transfer restrictions: Schedule II prescriptions can't be transferred between pharmacies in most states, requiring a new prescription each time
- Dose-specific shortages: A pharmacy may have Evekeo 5 mg but not 10 mg, or tablets but not ODT
- Insurance barriers: Even when found, prior authorization requirements or non-preferred status can delay filling
- Cost shock: Patients who find Evekeo but face $350-$600 cash prices may not be able to afford it
- Independent pharmacies with multiple wholesaler relationships
- Specialty pharmacies focused on psychiatry or pediatrics
- Hospital outpatient pharmacies that may have separate supply chains
- Consider both formulations: If Evekeo tablets are unavailable, Evekeo ODT may be in stock (available in 5 mg, 10 mg, 15 mg, and 20 mg)
- Discuss dose adjustments: If a patient's specific strength is unavailable, you may be able to prescribe an available strength with adjusted quantity
- 90-day supplies: When a pharmacy does have stock, a 90-day prescription (where regulations and insurance allow) reduces the frequency of the sourcing challenge
- Preferred alternative medication (e.g., generic mixed amphetamine salts, lisdexamfetamine)
- Conversion dose — note that Evekeo's 1:1 ratio is not directly equivalent mg-for-mg to Adderall's 3:1 ratio
- Patient's agreement to the backup plan
- Trigger point — at what point (e.g., 1 week without medication) to activate the switch
- Whether the patient's insurance covers Evekeo (many plans require prior authorization or don't cover it)
- Manufacturer savings programs through Azurity Pharmaceuticals
- Discount card options (GoodRx, SingleCare) that may reduce cash prices
- Patient assistance programs for uninsured or underinsured patients
- Adderall / generic mixed amphetamine salts: Closest pharmacological match, though the 3:1 d/l ratio differs from Evekeo's 1:1. May require dose adjustment.
- Dexedrine / generic dextroamphetamine: Pure d-amphetamine. More potent per milligram. Available in IR and ER formulations.
- Vyvanse / generic lisdexamfetamine: Prodrug with smoother onset and lower abuse potential. Once-daily dosing. Generic now available.
- Methylphenidate products: Different mechanism of action. Consider if patient has failed or not tolerated amphetamine-class medications.
- Current shortage status
- Steps the patient can take (including the Medfinder link)
- Instructions for contacting the office if they can't fill their prescription
- The documented backup medication plan
Frequently Asked Questions
Medfinder for Providers (medfinder.com/providers) lets clinical staff check real-time Evekeo availability at local pharmacies. Use it before sending prescriptions to ensure the receiving pharmacy has stock, avoiding wasted patient trips and failed fills.
Direct mg-for-mg conversion is not recommended. Evekeo's 1:1 d/l-amphetamine ratio differs from Adderall's 3:1 ratio, meaning equivalent clinical effects may occur at different total daily doses. Start with a comparable total daily dose of mixed amphetamine salts and titrate based on response and tolerability over 2-4 weeks.
Yes, Evekeo ODT contains the same active ingredient (amphetamine sulfate) in the same 1:1 racemic ratio. It's available in 5 mg, 10 mg, 15 mg, and 20 mg strengths. The ODT may have different availability from tablets since it's distributed through separate inventory channels. Confirm stock before prescribing.
Direct patients to the Azurity Pharmaceuticals savings program for commercially insured patients, discount cards like GoodRx and SingleCare, and patient assistance programs through NeedyMeds and RxAssist. Generic amphetamine sulfate ($30-$80/month) is significantly cheaper than brand Evekeo ($350-$600/month) when available.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsRelated articles
29,413 have already found their meds with Medfinder.
Start your search today.

![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)



